“Vascular Outlining”: Augmented Imaging for Transfemoral Access—A Preclinical Investigation
06 May 2017
08 January 2018
28 February 2018 (online)
Background Advanced visualization software tools have been used in clinics to improve the safety and accuracy of transcatheter procedure. Imaging techniques have greatly evolved during the era of transcatheter aortic valve implantation (TAVI). In a retrospective analysis, we investigated the feasibility of augmented fluoroscopy for iliofemoral access using a novel “Vascular Outlining” roadmapping technology.
Methods The Vascular Outlining prototype device (Philips Healthcare) application was used with iliofemoral angiography of 10 patients undergoing transfemoral TAVI. The software processes any conventional angiographic sequences, extracting the static outline of vessels and projecting the two-dimensional vessel margins as a roadmap on live fluoroscopy. Post-processed results were clinically assessed to determine whether the technical performance of the tool is sufficient.
Results Augmented imaging was possible in all investigated angiography sequences. The analysis of software-generated images showed accurate projection of the two-dimensional outline of the iliofemoral vessels as an overlay on the live fluoroscopy image in most cases. Overlay inaccuracy was only observed in cases with low contrast or patient movement.
Conclusion In static and contrasted angiography sequences, “Vascular Outlining” showed accurate image overlay. We identified that the quality of the vascular outline is dependent on the opacification of the contrast injection and the stability of the patient on the table. With further development. this application might increase the accuracy of femoral puncture and reduce the incidence of vascular complications. Clinical trials are needed to confirm these hypotheses.
- 1 Kodali SK, Williams MR, Smith CR. , et al; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366 (18) 1686-1695
- 2 Smith CR, Leon MB, Mack MJ. , et al; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364 (23) 2187-2198
- 3 Kempfert J, Rastan A, Holzhey D. , et al. Transapical aortic valve implantation: analysis of risk factors and learning experience in 299 patients. Circulation 2011; 124 (11, Suppl): S124-S129
- 4 Rodés-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 2011; 9 (01) 15-29
- 5 Webb JG, Altwegg L, Boone RH. , et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009; 119 (23) 3009-3016
- 6 Bande M, Michev I, Sharp AS, Chieffo A, Colombo A. Percutaneous transcatheter aortic valve implantation: past accomplishments, present achievements and applications, future perspectives. Cardiol Rev 2010; 18 (03) 111-124
- 7 Stratiev V, Guyon P, Teiger E, Collet JP. [Reducing the risk of vascular complications during percutaneous aortic valve replacement]. Ann Cardiol Angeiol (Paris) 2012; 61 (04) 281-286
- 8 Jelnin V, Dudiy Y, Einhorn BN, Kronzon I, Cohen HA, Ruiz CE. Clinical experience with percutaneous left ventricular transapical access for interventions in structural heart defects a safe access and secure exit. JACC Cardiovasc Interv 2011; 4 (08) 868-874
- 9 Beohar N, Kirtane AJ, Blackstone E. , et al. Trends in complications and outcomes of patients undergoing transfemoral transcatheter aortic valve replacement: experience from the PARTNER Continued Access Registry. JACC Cardiovasc Interv 2016; 9 (04) 355-363
- 10 Walther T, Hamm CW, Schuler G. , et al; GARY Executive Board. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY Registry. J Am Coll Cardiol 2015; 65 (20) 2173-2180
- 11 Adams DH, Popma JJ, Reardon MJ. , et al; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014; 370 (19) 1790-1798